Doccla’s Virtual Care Solutions Replacing Hospital Beds 

Health tech startup Doccla is tackling the shortages is introducing virtual care solutions in response to the global issue of hospital bed.

Health tech startup Doccla is tackling the shortages is introducing innovative virtual care solutions in response to the global issue of hospital bed, securing $46 million in funding. 

This funding will be used to support Doccla’s expansion in the UK healthcare expansion and drive further growth across Europe. 

What Is Hospital at Home? 

Doccla’s introduction of “hospital at home technology,” offers virtual care solutions for doctors to monitor patients remotely. The startup’s virtual hospital beds are designed to help in the care of patients discharged from hospitals or those who do not need hospital admission.  

The hospital at home technology operates through monitoring devices and a mobile app, collecting and integrating patient data into digital health records. Doctors can access this data via a dashboard and receive alerts when concerning changes in a patient’s condition occur. 

In an interview with TechCrunch, Doccla’s co-founder Martin Ratz, mentioned that with this technology, the company aims to reduce the burden on hospitals suffering from bed shortage, especially during health crisis.  

“We can help do things faster, better, cheaper than traditional CROs,” Ratz said, highlighting that these clinical trials are done with companies who oversee the trials based on a contract. 

Remote Healthcare Expansion 

In parallel to its core virtual hospital beds technology, Doccla is emboldening its position in remote healthcare through partnerships with local National Health Service (NHS) Trusts in the UK and Ireland’s Health Service Executive (HSE).  

Looking to broaden its market presence, Doccla is also eyeing the pharmaceutical sector to support virtual clinical trials, to minimize the need for patients to visit clinics for drug progress monitoring. This, in return, will restructure the drug trials process. 

Adopting this approach could simplify the drug trials process, making it more efficient and cost-effective.  

“We’re aiming to replicate what we do in the U.K. [while] recognizing that the underpinnings of [newer] markets are very different, particularly in terms of reimbursement,” Ratz said 

Will Virtual Care Solutions Lead the Way? 

The virtual care solutions market is becoming increasingly competitive, with companies like Huma and Graphnet offering similar services.  

Doccla believes its adaptability to any device and its accessibility-focused approach will help it stand out due to the app’s simple user interface, which allows patients to interact with clinicians via video conferencing and in-app messaging. 


Inside Telecom provides you with an extensive list of content covering all aspects of the Tech industry. Keep an eye on our Medtech section to stay informed and updated with our daily articles.